Inhibitors of met, vegfr and ret for use in the treatment of lung adenocarcinoma
Номер патента: EP2892532A1
Опубликовано: 15-07-2015
Автор(ы): Dana T. Aftab
Принадлежит: Exelixis Inc
Опубликовано: 15-07-2015
Автор(ы): Dana T. Aftab
Принадлежит: Exelixis Inc
Реферат: This invention is directed to the treatment of cancer in a patient, particularly a patient with lung adenocarcinoma, and more particularly a patient with KIF5B-RET fusion-positive non-small cell lung cancer, with an inhibitor of MET, VEGF, and RET which is a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors
Номер патента: EP1141280A1. Автор: Harmen Dolstra,Stefan Frederik Franciscus Verlinden,Petronella Van De Wiel - Van Kemenade. Владелец: Crucell Holand BV. Дата публикации: 2001-10-10.